Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about PURETECH HEALTH PLC
05/25 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
05/19 PURETECH HEALTH : Karuna to Present Tolerability Proof-of-Concept Data for KarXT..
05/19 KARUNA PHARMACEUTICALS : to Present KarXT Tolerability Proof-of-Concept Data for..
05/17 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
05/17 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
05/16 PURETECH HEALTH : Vedanta Biosciences Granted Three New U.S. Patents for Therape..
05/16 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
05/09 PURETECH HEALTH : Results of Annual General Meeting
05/09 PURETECH HEALTH : Announces Licensing Agreement between Commense and the Univers..
05/09 PURETECH HEALTH : Announces Initiation of Phase 2b mTORC1 Inhibitors Study in El..
05/06 PURETECH HEALTH : UBC has Commonsense for licence
05/05 PURETECH HEALTH : Announces Licensing Agreement between Commense and the Univers..
05/03 GELESIS : Announces €2.9 Million Award from Italian Ministry of Economic Develop..
04/24 CORRECT : PureTech Health's Chowrira Buys 34,000 Shares
04/24 DIRECTOR DEALINGS : PureTech Health's Chowrira Buys 34,000 Shares
More most relevant news
All news about PURETECH HEALTH PLC
05/25 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
05/25 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
05/19 PURETECH HEALTH : Karuna to Present Tolerability Proof-of-Concept Data for KarXT..
05/19 KARUNA PHARMACEUTICALS : to Present KarXT Tolerability Proof-of-Concept Data for..
05/17 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
05/17 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
05/16 PURETECH HEALTH : Vedanta Biosciences Granted Three New U.S. Patents for Therape..
05/16 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
05/11 PURETECH HEALTH : Announces Licensing Agreement between Commense and the Univers..
05/09 PURETECH HEALTH : Results of Annual General Meeting
More news
Sector news : Biotechnology & Medical Research - NEC
05/23 UK competition watchdog accuses Merck of obstructing biosimilars
05/22 Cross-border M&A between U.S. and European firms at 10 year high
05/22DJAMGEN : Another Gloomy Day for Amgen
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/09DJVERTEX PHARMACEUTICALS INCORPORATED : Trump's Pick to Lead FDA Has Backing of Bi..
05/07 REGENERON SHARES POISED FOR REBOUND : Barron's
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
05/25PureTech Health to Present at Jefferies 2017 Global Healthcare Conference  
05/16Puretech Health PLC's buy rating reiterated at N+1 Singer.  
05/10Puretech Health PLC's buy rating reiterated at Peel Hunt. GBX 259 PT.  
04/15Puretech Health : resTORbio Appoints Joan Mannick, M.D., as Chief Medical Off.. 
04/06PureTech Health : Announces Annual Results for Year Ended 31 December 2016  
More tweets
Qtime:7
Advertisement
Financials ($)
Sales 2017 1,85 M
EBIT 2017 -100 M
Net income 2017 -66,8 M
Debt 2017 2,93 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 201x
EV / Sales 2018 184x
Capitalization 369 M
More Financials
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Full-screen chart
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,13 $
Spread / Average Target 101%
Consensus details
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Michael F. MacLean Chief Financial Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC1.80%369
INCYTE CORPORATION38.04%27 518
QUINTILES IMS HOLDINGS..11.37%18 872
LONZA GROUP AG23.45%15 703
CELLTRION, INC.--.--%10 293
SEATTLE GENETICS, INC.25.11%9 358
More Results